116 related articles for article (PubMed ID: 123947)
1. [Calcium bucloxate: its use in ORL inflammatory pathology].
Gaillard J; Dumolard P
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):153-5. PubMed ID: 123947
[No Abstract] [Full Text] [Related]
2. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
Louyot P; Tamisier JN; Pourel J
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
[No Abstract] [Full Text] [Related]
3. [A new anti-inflammatory agent: calcium bucloxate in pediatrics].
Debray H; Galland A
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650
[No Abstract] [Full Text] [Related]
4. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
de Sèze S; Dryll A; Dreiser R
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
[No Abstract] [Full Text] [Related]
5. [Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
Beurey J; Weber M; Toussain P; Jacob M
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1432-4. PubMed ID: 4480072
[No Abstract] [Full Text] [Related]
6. [Esfar in an ENT department].
Traissac L; Pasquet J
Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331
[No Abstract] [Full Text] [Related]
7. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
Lagrue G; Masbernard A; Giudicelli C; Hirbec G
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
[No Abstract] [Full Text] [Related]
8. [Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
Gallais H; Casanova P
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1442-4. PubMed ID: 4480073
[No Abstract] [Full Text] [Related]
9. [Niflumic acid in cervicofacial pathology].
Gaillard J; Quilichini H
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1971 Nov; 20(9):1098-102. PubMed ID: 4257538
[No Abstract] [Full Text] [Related]
10. [Action of a novel anti-inflammatory agent: 804 CB on Masugi type experimental glomerulonephritis].
Vindel JA; Richer G; Khoury B; Hirbec G
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1378-84. PubMed ID: 4480067
[No Abstract] [Full Text] [Related]
11. [Non-steroidal anti-inflammatory agents: derivatives of 4-phenylbutyric and 4-phenyl-4-oxobutyric acid].
Krausz F; Demarne H; Vaillant J; Brunaud M; Navarro J
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1360-4. PubMed ID: 4480064
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology].
Roux O
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512
[No Abstract] [Full Text] [Related]
13. [A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)].
Krausz F; Breliere JC; Vaillant J; Brunaud M; Navarro J
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1364-7. PubMed ID: 4480065
[No Abstract] [Full Text] [Related]
14. [Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)].
Navarro J; Stoliaroff M; Savy JM; Berny C; Brunaud M
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1368-78. PubMed ID: 4480066
[No Abstract] [Full Text] [Related]
15. [Further contributions on the therapeutic action of Febutol in ORL].
Perrella F; Alinei D
Minerva Otorinolaringol; 1968; 18(2):94-8. PubMed ID: 5741565
[No Abstract] [Full Text] [Related]
16. [Niflumic acid in maxillofacial injuries and in sequela of surgical interventions in O.R.L].
Decroix G; Pilliaert JM
Lille Med; 1972 Feb; 17():Suppl 2:156-9. PubMed ID: 5034394
[No Abstract] [Full Text] [Related]
17. [Anti-inflammatory agents in ORL diseases. Introduction].
Passali D; Marcucci L
Acta Otorhinolaryngol Ital; 1990; 10 Suppl 28():5-9. PubMed ID: 2248027
[No Abstract] [Full Text] [Related]
18. [Results and considerations in the use of an anti-inflammatory and analgesic preparation in otorhinolaryngology].
Girardi G
Minerva Med; 1967 Apr; 58(32):1487-9. PubMed ID: 6029515
[No Abstract] [Full Text] [Related]
19. [Clinical study of the analgesic and anti-inflammatory activity of AF-864 (benzydamine hydrochloride) in otorhinolaryngology].
Di Fede S
Policlinico Prat; 1966 Nov; 73(46):1540-5. PubMed ID: 5998755
[No Abstract] [Full Text] [Related]
20. [Therapeutic experience in the use of Mebron tablet (DA-398) in otorhinolaryngologic field].
Kono K; Sekine K
Jibiinkoka; 1970 Sep; 42(9):711-3. PubMed ID: 5466086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
